OpenVSafe by OpenVAERS
Search V-safe

4U6-71312-89940

3 vaccinations 12 coded responses 21 check-ins 12 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
280 / NC
Registered
2021-04-17
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-20
    Dose 1 — Moderna
  2. 2021-04-17
    Registered in v-safe
  3. 2021-04-17
    Dose 2 — Moderna
  4. 2021-04-17
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-04-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Intermenstrual bleeding — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities
    Free text: Breakthrough bleeding
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  8. 2021-04-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Itching · Fatigue or tiredness, Rash, not including the immediate area around the injection site
    Adult check-in
  9. 2021-04-24
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-05-01
    Survey response — day 14, dose 2
    MedDRA: Rash — Feeling: Fair
    Free text: Rashes on face
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-05-08
    Survey response — day 21, dose 2
    MedDRA: Rash, Skin exfoliation — Feeling: Fair
    Free text: Face continues to break out in rashes. Skin on face continues to peel.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-05-17
    Survey response — day 28, dose 2
    MedDRA: Rash, Skin exfoliation — Feeling: Good
    Free text: Facial skin continues to breakout in rashes and peel.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-10-22
    Dose 3 — Moderna
  14. 2021-10-22
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  15. 2021-10-22
    Survey response — day 0, dose 3
    MedDRA: Injection site haemorrhage — Feeling: Fair · Site: Swelling
    Free text: Blood spurted out of injection site
    MedDRA releases: 2024-11 · check-in free text available
  16. 2021-10-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  17. 2021-10-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  18. 2021-10-25
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Redness, Swelling, Itching · Nausea · Be unable to do your normal daily activities
    Adult check-in
  19. 2021-10-26
    Survey response — days 1–6 daily, dose 3
    MedDRA: Hypoaesthesia, Paraesthesia — Feeling: Fair · Site: Redness, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Numbness tingling sensation in both legs
    MedDRA releases: 2024-11 · check-in free text available
  20. 2021-10-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Dizziness, Gait disturbance, Hypoaesthesia — Feeling: Fair · Site: Redness · Headache · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Dizzy, numbness in both legs, difficulty walking
    MedDRA releases: 2024-11 · check-in free text available
  21. 2021-10-28
    Survey response — days 1–6 daily, dose 3
    MedDRA: Hypoaesthesia — Feeling: Fair · Site: Redness, Itching · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Numbness in both legs and right arm
    MedDRA releases: 2024-11 · check-in free text available
  22. 2021-10-31
    Survey response — day 7, dose 3
    MedDRA: Hypoaesthesia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Numbness in both legs and right arm
    MedDRA releases: 2024-11 · check-in free text available
  23. 2021-11-05
    Survey response — day 14, dose 3
    MedDRA: Muscular weakness — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Worsening of leg muscle weakness
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-11-19
    Survey response — day 28, dose 3
    MedDRA: Gait inability, Muscular weakness — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Still unable to walk. Muscle weakness in legs.
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-12-03
    Survey response — day 42, dose 3
    MedDRA: Gait inability, Muscular weakness — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Still unable to walk. Weakness in legs. Just had a MRI scan of brain and spine.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-20Moderna
22021-04-17Moderna
32021-10-22Moderna No

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-19

Systemic reaction (other): Breakthrough bleeding

Release 8 — day 14, dose 2

2021-05-01

Symptoms: Rashes on face

Release 8 — day 21, dose 2

2021-05-08

Symptoms: Face continues to break out in rashes. Skin on face continues to peel.

Release 8 — day 28, dose 2

2021-05-17

Symptoms: Facial skin continues to breakout in rashes and peel.

Release 10 — day 0, dose 3

2021-10-22

Systemic reaction (other): Blood spurted out of injection site

Release 10 — days 1–6 daily, dose 3

2021-10-26

Systemic reaction (other): Numbness tingling sensation in both legs

2021-10-27

Systemic reaction (other): Dizzy, numbness in both legs, difficulty walking

2021-10-28

Systemic reaction (other): Numbness in both legs and right arm

Release 10 — day 7, dose 3

2021-10-31

Systemic reaction (other): Numbness in both legs and right arm

Release 10 — day 14, dose 3

2021-11-05

Symptoms: Worsening of leg muscle weakness

Release 10 — day 28, dose 3

2021-11-19

Symptoms: Still unable to walk. Muscle weakness in legs.

Release 10 — day 42, dose 3

2021-12-03

Symptoms: Still unable to walk. Weakness in legs. Just had a MRI scan of brain and spine.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDGait inability · · ✓
SDMuscular weakness · · ✓
SDRash ✓ ✓ ✓
SDSkin exfoliation ✓ ✓ ✓
SRODizziness · · ✓
SROGait disturbance · · ✓
SROHypoaesthesia · · ✓
SROInjection site haemorrhage · · ✓
SROIntermenstrual bleeding ✓ ✓ ✓
SROParaesthesia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…